HLA Complex Group 9 (Non-Protein Coding) (HCG9) (N-Term) Peptide
HCG9
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target
- HCG9 (HLA Complex Group 9 (Non-Protein Coding) (HCG9))
- Protein Region
- N-Term
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GWEQSQEESS AWSRQAPTPQ LESQEPHSPH SNRKHQLLVP KKGGPQLQGL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HCG9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HCG9 (HLA Complex Group 9 (Non-Protein Coding) (HCG9))
- Synonyms
- HCGIX Peptide, HCGIX4 Peptide, HLA complex group 9 (non-protein coding) Peptide, HCG9 Peptide
- Background
-
This gene lies within the MHC class I region on chromosome 6p21.3. This gene is believed to be non-coding, but its function has not been determined.
Alias Symbols: HCGIX, HCGIX4
Protein Size: 77 - Molecular Weight
- 9 kDa
- Gene ID
- 10255
- NCBI Accession
- NM_005844, NP_005835
- UniProt
- Q93065
-
You are here:
